Quantinno Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Quantinno Capital Management's JAZZ Position: Q3 2026 in Review
Quantinno Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 64% in Q3 2026, buying an estimated $43.5M and bringing the position to 449,662 shares worth $104M. The position accounts for 0.1% of the portfolio, ranked #226.
Quantinno Capital Management first reported a position in JAZZ in Q4 2018 and has held it in 24 quarters since. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Quantinno Capital Management held 449,662 shares of Jazz Pharmaceuticals worth $104M as of Q3 2026.
- Quantinno Capital Management bought 176,156 Jazz Pharmaceuticals shares in Q3 2026, an estimated $43.5M.
- Jazz Pharmaceuticals made up 0.1% of Quantinno Capital Management's portfolio in Q3 2026, its #226 holding.
- Quantinno Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 24 quarters since.
- 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.